Head to Head Study Epi proColon and FIT
NCT01580540 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 336
Last updated 2015-08-04
Summary
The study aims to show non-inferiority in the clinical performance of the investigational assay, Epi proColon, to FIT using matched blood and stool specimens from screening-guideline eligible subjects.
Conditions
Sponsors & Collaborators
-
Epigenomics, Inc
lead INDUSTRY
Principal Investigators
-
Juergen Beck, MD · Epigenomics, Inc
-
Neil Mucci · Epigenomics, Inc
Eligibility
- Min Age
- 50 Years
- Max Age
- 84 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2012-11-30
- Completion
- 2012-11-30
Countries
- United States
- Puerto Rico
Study Locations
More Related Trials
-
Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay
NCT00696345 ·Status: COMPLETED
-
Prospective Clinical Validation of a Novel Multitarget FIT in CRC Screening
NCT05314309 ·Status: UNKNOWN
-
Assessing Repeat Fit Testing for CRC
NCT03248661 ·Status: COMPLETED ·Phase: PHASE3
-
Maximizing Yield of the Fecal Immunochemical Test for Colorectal Cancer Screening
NCT01634126 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Community Collaboration to Advance Racial/Ethnic Equity in CRC Screening
NCT05714644 ·Status: COMPLETED ·Phase: NA
-
Assessment of Septin9 Biomarker for Detection of Colorectal Cancer in Patients With Positive Fecal Immunochemical Test
NCT01574677 ·Status: WITHDRAWN
-
Implementing Fit Kit Colorectal Cancer (CRC) Screening in High Risk Populations
NCT04848051 ·Status: COMPLETED ·Phase: NA
-
Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM)
NCT01239082 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Outreach and Choice in Colorectal Cancer Screening
NCT04940442 ·Status: UNKNOWN ·Phase: NA
-
A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers
NCT06568016 ·Status: RECRUITING ·Phase: NA
-
Combining Risk Factors and Faecal Immunochemical Testing in Colorectal Cancer Screening: a Randomized Controlled Trial
NCT04490551 ·Status: COMPLETED ·Phase: NA
-
Point of Care Faecal Immunochemical Testing for Colorectal Cancer
NCT04402424 ·Status: COMPLETED
-
An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now
NCT03728348 ·Status: COMPLETED
-
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
NCT01260168 ·Status: COMPLETED
-
PRESEPT Study: Evaluation of SEPT9 Biomarker Performance for Colorectal Cancer Screening
NCT00855348 ·Status: COMPLETED
-
4-week Serial FIT Analysis in Patients With CRC
NCT04242901 ·Status: COMPLETED
-
Scaling CRC Screening Through Outreach, Referral, and Engagement (SCORE)
NCT04406714 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
NCT00843375 ·Status: RECRUITING
-
A Study on a Blood-based Dual-target Test for CRC Detection
NCT05508503 ·Status: COMPLETED
-
Screening for Stomach Diseases and Colorectal Neoplasms With the Fecal Testing
NCT01741363 ·Status: COMPLETED ·Phase: NA
-
Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal Cancer
NCT00102011 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Effectiveness of FITs With Colonoscopy
NCT03264898 ·Status: COMPLETED
-
Screening More Patients for Colorectal Cancer Through Adapting and Refining Targeted Evidence-Based Interventions in Rural Settings, SMARTER CRC
NCT04890054 ·Status: COMPLETED ·Phase: NA
-
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
NCT05612347 ·Status: RECRUITING ·Phase: NA
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
NCT05903885 ·Status: RECRUITING ·Phase: NA